Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

Parsippany, NJ-based Zoetis Inc. came into existence following Pfizer’s decision ... parasiticides, dermatology, other pharmaceutical products, pain and sedation, medicated feed additives ...

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

We are delighted to welcome Kristen and Nancy to our Board of Directors,” said Tom King, Executive Chairman of Achieve’s Board of Directors. “Their wealth of knowledge and experience in strategic ...

New Delhi: Pharmaceutical major Pfizer Products India has got the go-ahead from the ... At the recent SEC meeting for dermatology and allergy held on 5th and 6th December 2024, the expert panel ...

And as you're about to notice, not only were the pharmaceutical products they created over ... cardiovascular, dermatology, infectious diseases, metabolism, neuroscience, oncology, ophthalmology ...

Ziarco is based on Pfizer's old research site, now reborn as a science business cluster, Discovery Park. Novartis says the acquisition will augment its dermatology portfolio and pipeline ...

Pfizer's stock has underperformed, but management's focus on R&D and cost efficiencies should boost margins and free cash flow, supporting a Buy rating. Despite political headwinds, PFE's ...

The company's adjusted gross margin of 70% in Q3-24 reflects challenges from an unfavorable mix of COVID-19 products and royalty expenses but highlights ongoing cost control measures. Pfizer ...